Consumption and ocurrence of antidepressants (SSRIs) in pre-and post-COVID-19 pandemic, their environmental impact and innovative removal methods: A review

N Diaz-Camal, JD Cardoso-Vera, H Islas-Flores… - Science of The Total …, 2022 - Elsevier
Selective serotonin reuptake inhibitors (SSRIs) are pharmaceuticals whose consumption
has increased significantly. They are prescribed as first-line treatment in mental disorders …

Surging trends in prescriptions and costs of antidepressants in England amid COVID-19

SA Rabeea, HA Merchant, MU Khan, CS Kow… - DARU Journal of …, 2021 - Springer
The social restrictions amid coronavirus disease 2019 (COVID-19) pandemic have posed a
serious threat to mental health and have implications in the use of medications for mental …

National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: a population representative …

Y Luo, Y Kataoka, EG Ostinelli, A Cipriani… - Frontiers in …, 2020 - frontiersin.org
Few studies have delineated the real-world, long-term trends of prescription patterns of
antidepressants for patients with major depressive disorder (MDD). This study aims to …

Discovery of 1-[2-(2, 4-dimethylphenylsulfanyl) phenyl] piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder

B Bang-Andersen, T Ruhland… - Journal of medicinal …, 2011 - ACS Publications
The synthesis and structure− activity relationship of a novel series of compounds with
combined effects on 5-HT3A and 5-HT1A receptors and on the serotonin (5-HT) transporter …

[HTML][HTML] Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment

C McCabe, Z Mishor, PJ Cowen, CJ Harmer - Biological psychiatry, 2010 - Elsevier
BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are popular medications for
anxiety and depression, but their effectiveness, particularly in patients with prominent …

Results of the European Group for the Study of Resistant Depression (GSRD)—basis for further research and clinical practice

L Bartova, M Dold, A Kautzky, C Fabbri… - The World Journal of …, 2019 - Taylor & Francis
Objectives: The overview outlines two decades of research from the European Group for the
Study of Resistant Depression (GSRD) that fundamentally impacted evidence-based …

Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological …

V Abbing-Karahagopian, C Huerta… - European journal of …, 2014 - Springer
Purpose Drug utilization studies have applied different methods to various data types to
describe medication use, which hampers comparisons across populations. The aim of this …

Pharmaceutical expenditure and policies: past trends and future challenges

A Belloni, D Morgan, V Paris - 2016 - oecd-ilibrary.org
Across OECD countries, pharmaceutical spending reached around USD 800 billion in 2013,
accounting for about 20% of total health spending on average when pharmaceutical …

Antidepressant medications and osteoporosis

R Rizzoli, C Cooper, JY Reginster, B Abrahamsen… - Bone, 2012 - Elsevier
Use of antidepressant medications that act on the serotonin system has been linked to
detrimental impacts on bone mineral density (BMD), and to osteoporosis. This article …

Anti-inflammatory treatment efficacy in major depressive disorder: a systematic review of meta-analyses

MS Simon, G Arteaga-Henríquez… - Neuropsychiatric …, 2023 - Taylor & Francis
Purpose Immune imbalances in major depressive disorder (MDD) have been targeted by
anti-inflammatory treatment approaches in clinical trials to increase responsiveness to …